Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies

Martha C. Contreras-Romo, Marlet Martínez-Archundia, Omar Deeb, Magdalena J. Ślusarz, Gema Ramírez-Salinas, Ramõn Garduño-Juárez, Andrés Quintanar-Stephano, Guillermo Ramírez-Galicia, José Correa-Basurto

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Vaptans are compounds that act as non-peptide vasopressin receptor antagonists. These compounds have diverse chemical structures. In this study, we used a combined approach of protein folding, molecular dynamics simulations, docking, and quantitative structure-activity relationship (QSAR) to elucidate the detailed interaction of the vasopressin receptor V1a (V1aR) with some of its blockers (134). QSAR studies were performed using MLR analysis and were gathered into one group to perform an artificial neural network (ANN) analysis. For each molecule, 1481 molecular descriptors were calculated. Additionally, 15 quantum chemical descriptors were calculated. The final equation was developed by choosing the optimal combination of descriptors after removing the outliers. Molecular modeling enabled us to obtain a reliable tridimensional model of V1aR. The docking results indicated that the great majority of ligands reach the binding site under π-π, π-cation, and hydrophobic interactions. The QSAR studies demonstrated that the heteroatoms N and O are important for ligand recognition, which could explain the structural diversity of ligands that reach V1aR. Exploration of V1aR under theoretical studies (MD simulations, QSAR and docking studies) to depict the principal recognition properties which could be use for drug design.

Original languageEnglish
Pages (from-to)207-223
Number of pages17
JournalChemical Biology and Drug Design
Volume83
Issue number2
DOIs
StatePublished - Feb 2014

Keywords

  • MD simulations
  • QSAR studies
  • V1aR
  • docking
  • vaptans

Fingerprint

Dive into the research topics of 'Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies'. Together they form a unique fingerprint.

Cite this